Leukocyte Differential Gene Expression Prognostic Value for High Versus Low Seizure Frequency in Temporal Lobe Epilepsy

Overview

Journal BMC Neurol

Publisher Biomed Central

Specialty Neurology

Date 2024 Jan 3

PMID 38166692

Authors

Ryan Sprissler

Michael Hammer

David Labiner

Neil Joshi

Albert Alan

Martin Weinand

Affiliations

Soon will be listed here.

Abstract

Background: This study was performed to test the hypothesis that systemic leukocyte gene expression has prognostic value differentiating low from high seizure frequency refractory temporal lobe epilepsy (TLE).

Methods: A consecutive series of patients with refractory temporal lobe epilepsy was studied. Based on a median baseline seizure frequency of 2.0 seizures per month, low versus high seizure frequency was defined as ≤ 2 seizures/month and > 2 seizures/month, respectively. Systemic leukocyte gene expression was analyzed for prognostic value for TLE seizure frequency. All differentially expressed genes were analyzed, with Ingenuity® Pathway Analysis (IPA®) and Reactome, to identify leukocyte gene expression and biological pathways with prognostic value for seizure frequency.

Results: There were ten males and six females with a mean age of 39.4 years (range: 16 to 62 years, standard error of mean: 3.6 years). There were five patients in the high and eleven patients in the low seizure frequency cohorts, respectively. Based on a threshold of twofold change (p < 0.001, FC > 2.0, FDR < 0.05) and expression within at least two pathways from both Reactome and Ingenuity® Pathway Analysis (IPA®), 13 differentially expressed leukocyte genes were identified which were all over-expressed in the low when compared to the high seizure frequency groups, including NCF2, HMOX1, RHOB, FCGR2A, PRKCD, RAC2, TLR1, CHP1, TNFRSF1A, IFNGR1, LYN, MYD88, and CASP1. Similar analysis identified four differentially expressed genes which were all over-expressed in the high when compared to the low seizure frequency groups, including AK1, F2R, GNB5, and TYMS.

Conclusions: Low and high seizure frequency TLE are predicted by the respective upregulation and downregulation of specific leukocyte genes involved in canonical pathways of neuroinflammation, oxidative stress and lipid peroxidation, GABA (γ-aminobutyric acid) inhibition, and AMPA and NMDA receptor signaling. Furthermore, high seizure frequency-TLE is distinguished prognostically from low seizure frequency-TLE by differentially increased specific leukocyte gene expression involved in GABA inhibition and NMDA receptor signaling. High and low seizure frequency patients appear to represent two mechanistically different forms of temporal lobe epilepsy based on leukocyte gene expression.

References

Zhang Z, Liao W, Bernhardt B, Wang Z, Sun K, Yang F . Brain iron redistribution in mesial temporal lobe epilepsy: a susceptibility-weighted magnetic resonance imaging study. BMC Neurosci. 2014; 15:117. PMC: 4243317. DOI: 10.1186/s12868-014-0117-3. View

Levandowski C, Mailloux C, Ferrara T, Gowan K, Ben S, Jin Y . NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome. Proc Natl Acad Sci U S A. 2013; 110(8):2952-6. PMC: 3581876. DOI: 10.1073/pnas.1222808110. View

de Weerd N, Nguyen T . The interferons and their receptors--distribution and regulation. Immunol Cell Biol. 2012; 90(5):483-91. PMC: 7165917. DOI: 10.1038/icb.2012.9. View

Li T, Zhai X, Jiang J, Song X, Han W, Ma J . Intraperitoneal injection of IL-4/IFN-γ modulates the proportions of microglial phenotypes and improves epilepsy outcomes in a pilocarpine model of acquired epilepsy. Brain Res. 2016; 1657:120-129. DOI: 10.1016/j.brainres.2016.12.006. View

Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

Eynan M, Ertracht O, Gancz H, Kashi Y, Arieli Y . Prolonged latency to CNS-O2 toxicity induced by heat acclimation in rats is associated with increased antioxidative defenses and metabolic energy preservation. J Appl Physiol (1985). 2012; 113(4):595-601. DOI: 10.1152/japplphysiol.00228.2012. View

Hanke M, Kielian T . Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond). 2011; 121(9):367-87. PMC: 4231819. DOI: 10.1042/CS20110164. View

Macfarlane S, Seatter M, Kanke T, HUNTER G, Plevin R . Proteinase-activated receptors. Pharmacol Rev. 2001; 53(2):245-82. View

Narumiya S, Thumkeo D . Rho signaling research: history, current status and future directions. FEBS Lett. 2018; 592(11):1763-1776. PMC: 6032899. DOI: 10.1002/1873-3468.13087. View

10.

Garcia P, Laxer K, van der Grond J, Hugg J, Matson G, Weiner M . Correlation of seizure frequency with N-acetyl-aspartate levels determined by 1H magnetic resonance spectroscopic imaging. Magn Reson Imaging. 1997; 15(4):475-8. DOI: 10.1016/s0730-725x(96)00327-x. View

11.

Li G, Bauer S, Nowak M, Norwood B, Tackenberg B, Rosenow F . Cytokines and epilepsy. Seizure. 2011; 20(3):249-56. DOI: 10.1016/j.seizure.2010.12.005. View

12.

Asadi-Pooya A, Rostami C . History of surgery for temporal lobe epilepsy. Epilepsy Behav. 2017; 70(Pt A):57-60. DOI: 10.1016/j.yebeh.2017.02.020. View

13.

Ambrogini P, Torquato P, Bartolini D, Albertini M, Lattanzi D, Di Palma M . Excitotoxicity, neuroinflammation and oxidant stress as molecular bases of epileptogenesis and epilepsy-derived neurodegeneration: The role of vitamin E. Biochim Biophys Acta Mol Basis Dis. 2019; 1865(6):1098-1112. DOI: 10.1016/j.bbadis.2019.01.026. View

14.

Ionescu M . Adenylate Kinase: A Ubiquitous Enzyme Correlated with Medical Conditions. Protein J. 2019; 38(2):120-133. DOI: 10.1007/s10930-019-09811-0. View

15.

Neumann H, Schmidt H, Cavalie A, Jenne D, Wekerle H . Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha. J Exp Med. 1997; 185(2):305-16. PMC: 2196130. DOI: 10.1084/jem.185.2.305. View

16.

Wang N, Han X, Liu H, Zhao T, Li J, Feng Y . Myeloid differentiation factor 88 is up-regulated in epileptic brain and contributes to experimental seizures in rats. Exp Neurol. 2017; 295:23-35. DOI: 10.1016/j.expneurol.2017.05.008. View

17.

Wang Y, Wang D, Guo D . Interictal cytokine levels were correlated to seizure severity of epileptic patients: a retrospective study on 1218 epileptic patients. J Transl Med. 2015; 13:378. PMC: 4666166. DOI: 10.1186/s12967-015-0742-3. View

18.

Hammer M, Sprissler R, Bina R, Lau B, Johnstone L, Walter C . Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency. Epilepsy Res. 2019; 155:106145. DOI: 10.1016/j.eplepsyres.2019.05.013. View

19.

Vezzani A, French J, Bartfai T, Baram T . The role of inflammation in epilepsy. Nat Rev Neurol. 2010; 7(1):31-40. PMC: 3378051. DOI: 10.1038/nrneurol.2010.178. View

20.

Balosso S, Maroso M, Sanchez-Alavez M, Ravizza T, Frasca A, Bartfai T . A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain. 2008; 131(Pt 12):3256-65. PMC: 2724908. DOI: 10.1093/brain/awn271. View